AVBP
Price
$33.58
Change
+$0.88 (+2.69%)
Updated
Jun 23, 04:02 PM (EDT)
Capitalization
1.52B
56 days until earnings call
Intraday BUY SELL Signals
KROS
Price
$11.25
Change
+$0.27 (+2.46%)
Updated
Jun 23, 04:09 PM (EDT)
Capitalization
217.51M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs KROS

AVBP vs KROS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AVBP vs. KROS commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Buy and KROS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (AVBP: $32.70 vs. KROS: $10.99)
Brand notoriety: AVBP and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 146% vs. KROS: 115%
Market capitalization -- AVBP: $1.52B vs. KROS: $217.51M
AVBP [@Biotechnology] is valued at $1.52B. KROS’s [@Biotechnology] market capitalization is $217.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 4 bullish TA indicator(s).

  • AVBP’s TA Score: 4 bullish, 5 bearish.
  • KROS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than KROS.

Price Growth

AVBP (@Biotechnology) experienced а +7.92% price change this week, while KROS (@Biotechnology) price change was +7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

AVBP is expected to report earnings on Aug 18, 2026.

KROS is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($1.52B) has a higher market cap than KROS($218M). AVBP YTD gains are higher at: 62.525 vs. KROS (-46.022). KROS has higher annual earnings (EBITDA): -108.78M vs. AVBP (-156.87M). AVBP has more cash in the bank: 326M vs. KROS (281M). AVBP has less debt than KROS: AVBP (419K) vs KROS (16.3M). KROS has higher revenues than AVBP: KROS (33.2M) vs AVBP (0).
AVBPKROSAVBP / KROS
Capitalization1.52B218M699%
EBITDA-156.87M-108.78M144%
Gain YTD62.525-46.022-136%
P/E RatioN/A4.78-
Revenue033.2M-
Total Cash326M281M116%
Total Debt419K16.3M3%
FUNDAMENTALS RATINGS
KROS: Fundamental Ratings
KROS
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVBPKROS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 16 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
KROS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GEVG34.230.83
+2.47%
Leverage Shares 2X Long GEV Daily ETF
PWS32.040.39
+1.22%
Pacer WealthShield ETF
IGBH24.700.06
+0.24%
iShares Interest Rate Hdg L/T Corp BdETF
ISCG63.770.06
+0.09%
iShares Morningstar Small-Cap Growth ETF
COII7.52N/A
N/A
REX COIN Growth & Income ETF

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with DNLI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+3.02%
DNLI - AVBP
45%
Loosely correlated
+3.17%
PCVX - AVBP
45%
Loosely correlated
+1.30%
EDIT - AVBP
44%
Loosely correlated
+3.53%
ABEO - AVBP
43%
Loosely correlated
-0.35%
VIR - AVBP
43%
Loosely correlated
+4.48%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+3.19%
AXON - KROS
43%
Loosely correlated
-3.16%
MGTX - KROS
43%
Loosely correlated
+1.41%
AVBP - KROS
43%
Loosely correlated
+3.02%
XNCR - KROS
41%
Loosely correlated
+10.84%
RGNX - KROS
41%
Loosely correlated
+16.22%
More